Lexicon Pharmaceuticals (LXRX) Reports In-Line Q4 EPS
Tweet Send to a Friend
Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q4 EPS of ($0.05) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
